HALOZYME THERAPEUTICS INC

Ticker: HALO CUSIP: 40637H109 Class: EQTY

OCONNOR, A Distinct Business Unit of UBS ASSET MANAGEMENT AM's Holding History (CIK: 0001132716)

Note: Option positions (PUT/CALL) are excluded.

Q3 2024
Shares 24,683 Value ($000) $1,413 Avg Close $57.33 Range $50.68 - $65.53
Q2 2024
Shares 33,683 Value ($000) $1,764 Avg Close $43.86 Range $37.73 - $53.00
Q1 2024
Shares 59,683 Value ($000) $2,428 Avg Close $37.49 Range $33.15 - $42.64
Q4 2023
Shares 27,683 Value ($000) $1,023 Avg Close $37.66 Range $32.83 - $42.82
Q3 2023
Shares 68,543 Value ($000) $2,618 Avg Close $40.96 Range $35.71 - $45.00
Q2 2023
Shares 78,543 Value ($000) $2,833 Avg Close $34.12 Range $29.85 - $38.80
Q1 2023
Shares 69,920 Value ($000) $2,670 Avg Close $46.91 Range $32.83 - $57.00
Q3 2022
Shares 83,937 Value ($000) $3,319,000 Avg Close $44.20 Range $38.03 - $52.98
Q2 2022
Shares 87,937 Value ($000) $3,869,000 Avg Close $43.25 Range $36.95 - $48.58